Is Celularity Inc (CELUW) overvalued? · rev $54.2M
Celularity Inc (CELUW) common stock listed on US.
This page asks whether Celularity Inc (CELUW) looks expensive on cached numbers — not a short thesis.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
CELUW currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CELUW 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CELUW stock page for the full model, not this heading.
Not investment advice.